Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

NEOSH-101 increases hair growth significantly in men with androgenetic alopecia

Jan. 10, 2007

Merck KGaA patents novel tyrosinase inhibitors

Jan. 5, 2007

Warner Chilcott and Foamix to develop antibiotic foam for acne

Jan. 5, 2007

MediGene acquires E.U. rights to Oracea, establishes E.U. sales force

Dec. 27, 2006

Biofrontera advances phase IIb/III trial of BF-200 ALA in actinic keratosis

Dec. 15, 2006

New PDE4/TNF-alpha inhibitors emerge from Nippon Shinyaku R&D

Nov. 30, 2006

TRK-820 filed in Japan for severe uremic pruritus in hemodialysis patients

Nov. 29, 2006

Positive results for Atopiclair in pediatric atopic dermatitis

Nov. 28, 2006

Novel agents for dermatological disorders disclosed in recent Pfizer patent

Nov. 24, 2006

IND amendment for AVR-118 to include topical and intralesional therapy

Nov. 16, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...